The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Role for Excitatory Amino Acids in Methamphetamine-Induced Nigrostriatal Dopaminergic Toxicity
Abstract
The systemic administration of either methamphetamine or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to experimental animals produces degenerative changes in nigrostriatal dopaminergic neurons or their axon terminals. This study was conducted to determine if excitatory amino acids, which appear to be involved in various neurodegenerative disorders, might also contribute to the dopaminergic neurotoxicity produced in mice by either methamphetamine or MPTP. MK-801, phencyclidine, and ketamine, noncompetitive antagonists of one subtype of excitatory amino acid receptor, the N-methyl-D-aspartate receptor, provided substantial protection against neurotoxicity produced by methamphetamine but not that produced by MPTP. These findings indicate that excitatory amino acids play an important role in the nigrostriatal dopaminergic damage induced by methamphetamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MacDermott, A. B., Mayer, M. L., Westbrook, G. L., Smith, S. J., & Barker, J. L. (1986) · Nature · doi:10.1038/321519a0 · Cited by 1,835
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
Wong, E. H., Kemp, J. A., Priestley, T., Knight, A. R., Woodruff, G. N., & Iversen, L. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.7104 · Cited by 1,819
Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain
Simon, R. P., Swan, J. H., Griffiths, T., & Meldrum, B. S. (1984) · Science · doi:10.1126/science.6093256 · Cited by 1,682
Glutamate neurotoxicity in cortical cell culture
Choi, D., Maulucci-Gedde, M., & Kriegstein, A. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00357.1987 · Cited by 1,384
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Self-citationLesion of striatal neurons with kainic acid provides a model for Huntington's chorea
COYLE, J. T., & SCHWARCZ, R. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,248
Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
Heikkila, R. E., Hess, A., & Duvoisin, R. C. (1984) · Science · doi:10.1126/science.6610213 · Cited by 1,009
Self-citationIntraventricular kainic acid preferentially destroys hippocampal pyramidal cells
NADLER, J. V., PERRY, B. W., & COTMAN, C. W. (1978) · Nature · doi:10.1038/271676a0 · Cited by 743
Hypoglycemia-Induced Neuronal Damage Prevented by an N -Methyl-D-Aspartate Antagonist
Wieloch, T. (1985) · Science · doi:10.1126/science.2996146 · Cited by 673
Gill, R., Foster, A., & Woodruff, G. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-10-03343.1987 · Cited by 640
Cited by
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Carlsson, M., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,082
The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
Wolf, M. E. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00090-7 · Cited by 934
Danysz, W., & Parsons, C. G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01382-6 · Cited by 649
McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602
“, two to four times at 2 hr intervals) (Sonsalla et al., 1989; Melega et al., 1993).”
BackgroundAnimal models of Parkinson's disease
Betarbet, R., Sherer, T. B., & Greenamyre, J. T. (2002) · BioEssays · doi:10.1002/bies.10067 · Cited by 592
Methamphetamine toxicity and messengers of death
Krasnova, I. N., & Cadet, J. L. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.03.002 · Cited by 589
Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists
Turski, L., Bressler, K., Jürgen Rettig, K., Löschmann, P.-A., & Wachtel, H. (1991) · Nature · doi:10.1038/349414a0 · Cited by 546
Davidson, C., Gow, A. J., Lee, T. H., & Ellinwood, E. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00054-6 · Cited by 521
Invited Review Free radicals and the pathobiology of brain dopamine systems
Cadet, J. L., & Brannock, C. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00031-4 · Cited by 499
Gerlach, M., & Riederer, P. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291788 · Cited by 498
Glutamatergic substrates of drug addiction and alcoholism
Gass, J. T., & Olive, M. F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.039 · Cited by 484
Thiruchelvam, M., Richfield, E. K., Baggs, R. B., Tank, A. W., & Cory-Slechta, D. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09207.2000 · Cited by 471
Cubells, J., Rayport, S., Rajendran, G., & Sulzer, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02260.1994 · Cited by 448
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
Carlsson, M., & Carlsson, A. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258633 · Cited by 423
Green, A. R., Cross, A. J., & Goodwin, G. M. (1995) · Psychopharmacology · doi:10.1007/bf02246288 · Cited by 415
NORDAHL, T. E., Salo, R. E., & Leamon, M. H. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.3.317 · Cited by 371
Nash, J. F., & Yamamoto, B. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)90713-j · Cited by 354
Malberg, J. E., & Seiden, L. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-05086.1998 · Cited by 344
The Role of Monoamine Metabolism in Oxidative Glutamate Toxicity
Maher, P., & Davis, J. B. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-20-06394.1996 · Cited by 336
Thiruchelvam, M., Brockel, B. J., Richfield, E. K., Baggs, R. B., & Cory-Slechta, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02496-3 · Cited by 324
Glutamate and Parkinson’s disease
Blandini, F., Porter, R. H. P., & Greenamyre, J. T. (1996) · Molecular Neurobiology · doi:10.1007/bf02740748 · Cited by 323
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies
Danysz, W., Parsons, C. G., Kornhuber, J., Schmidt, W. J., & Quack, G. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00037-1 · Cited by 322
MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease
Gerlach, M., Riederer, P., Przuntek, H., & Youdim, M. B. H. (1991) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(91)90073-q · Cited by 307
STEELE, T. D., McCANN, U. D., & RICAURTE, G. A. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03330.x · Cited by 289
NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted rats
Klockgether, T., & Turski, L. (1990) · Annals of Neurology · doi:10.1002/ana.410280411 · Cited by 284
The Effects of Methamphetamine on the Production of Free Radicals and Oxidative Stress
Yamamoto, B. K., & Zhu, W. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37769-9 · Cited by 281
Methamphetamine‐induced neurotoxicity: Roles for glutamate and dopamine efflux
Stephans, S. E., & Yamamoto, B. K. (1994) · Synapse · doi:10.1002/syn.890170310 · Cited by 278
Dopaminergic Mechanisms in Idiopathic and Drug-induced Psychoses
Lieberman, J. A., Kinon, B. J., & Loebel, A. D. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.1.97 · Cited by 274
Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms
Cadet, J. L., Krasnova, I. N., Jayanthi, S., & Lyles, J. (2007) · Neurotoxicity Research · doi:10.1007/bf03033567 · Cited by 272
Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04861.1998 · Cited by 266
Cadet, J. L., Sheng, P., All, S., Rothman, R., Carlson, E., & Epstein, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010380.x · Cited by 263
Miller, D. B., & O'Callaghan, J. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22434-x · Cited by 259
The role of the locus coeruleus in the development of Parkinson's disease
Gesi, M., Soldani, P., Giorgi, F. S., Santinami, A., Bonaccorsi, I., & Fornai, F. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00028-2 · Cited by 258
Ryan, R. E., Ross, S. A., Drago, J., & Loiacono, R. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703989 · Cited by 188
Harrigan, T. J., Abdullaev, I. F., Jourd’heuil, D., & Mongin, A. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05553.x · Cited by 103
Obesity exacerbates chemically induced neurodegeneration
Sriram, K., Benkovic, S. A., Miller, D. B., & O’Callaghan, J. P. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00306-8 · Cited by 78
Antioxidant effect of simvastatin throught oxidative imbalance caused by lisdexamfetamine dimesylate
Eger, G. A., Ferreira, V. V., Batista, C. R., Bonde, H., Lima, D. D. D., Wyse, A. T. S., Cruz, J. N. D., Rodrigues, A. F., Magro, D. D. D., & Cruz, J. G. P. D. (2016) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201620140490 · Cited by 13
Metadata
- Authors
- Sonsalla, P. K., Nicklas, W. J., & Heikkila, R. E.
- Venue
- Science
- Published
- 1989-01-20
- Volume
- 243
- Issue
- 4889
- Pages
- 398-400
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2044779910
- Cited by
- 490
- References
- 34
- FWCI
- 30.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.